mTHPC--a drug on its way from second to third generation photosensitizer?

5,10,15,20-Tetrakis(3-hydroxyphenyl)chlorin (mTHPC, Temoporfin) is a widely investigated second generation photosensitizer. Its initial use in solution form (Foscan®) is now complemented by nanoformulations (Fospeg®, Foslip®) and new chemical derivatives related to the basic hydroxyphenylporphyrin framework. Advances in formulation, chemical modifications and targeting strategies open the way for third generation photosensitizers and give an illustrative example for the developmental process of new photoactive drugs.

[1]  H. S. de Bruijn,et al.  In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging , 2011, Lasers in Medical Science.

[2]  H. Burrows,et al.  A New Nonconjugated Naphthalene Derivative of Meso‐tetra‐(3‐hydroxy)‐phenyl‐porphyrin as a Potential Sensitizer for Photodynamic Therapy , 2010, Photochemistry and photobiology.

[3]  G. Manda,et al.  Microwave Synthesis, Basic Spectral and Biological Evaluation of Some Copper (II) Mesoporphyrinic Complexes , 2010, Molecules.

[4]  C. Maake,et al.  Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro. , 2011, Photodiagnosis and photodynamic therapy.

[5]  E. Monti,et al.  Photodynamic effects of novel 5,15-diaryl-tetrapyrrole derivatives on human colon carcinoma cells. , 2009, Bioorganic & medicinal chemistry.

[6]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[7]  H. van den Bergh,et al.  Antibody–fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice , 1991, Cancer.

[8]  S. May,et al.  Transfer mechanism of temoporfin between liposomal membranes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[9]  M. Roos,et al.  Optimizing Photodynamic Therapy: In vivo Pharmacokinetics of Liposomal meta-(Tetrahydroxyphenyl)Chlorin in Feline Squamous Cell Carcinoma , 2005, Clinical Cancer Research.

[10]  Gonçalo F. F. Sá,et al.  Synthesis and photophysical characterization of a library of photostable halogenated bacteriochlorins: an access to near infrared chemistry , 2010 .

[11]  M. Barberi-Heyob,et al.  Modulation of photosensitization processes for an improved targeted photodynamic therapy. , 2010, Current medicinal chemistry.

[12]  D. Kessel.  Photodynamic therapy: from the beginning. , 2004, Photodiagnosis and photodynamic therapy.

[13]  M C Berenbaum,et al.  Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. , 1989, The Biochemical journal.

[14]  R. Boyle,et al.  Synthetic approaches for the conjugation of porphyrins and related macrocycles to peptides and proteins , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[15]  R. Pandey,et al.  Porphyrin-carbohydrate conjugates: impact of carbohydrate moieties in photodynamic therapy (PDT). , 2008, Anti-cancer agents in medicinal chemistry.

[16]  P. Maillard,et al.  Microwave-mediated ‘click-chemistry’ synthesis of glycoporphyrin derivatives and in vitro photocytotoxicity for application in photodynamic therapy , 2011 .

[17]  J. Blais,et al.  Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins. , 2003, Bioorganic & medicinal chemistry.

[18]  M. Senge,et al.  Lead structures for applications in photodynamic therapy part 2: synthetic studies for photo-triggered release systems of bioconjugate porphyrin photosensitizers , 2009 .

[19]  J. Lindsey,et al.  Investigation of the scope of a new route to ABCD-bilanes and ABCD-porphyrins. , 2008, The Journal of organic chemistry.

[20]  Zhiyuan Hu,et al.  Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  J. Blais,et al.  In vitro phototoxicity of glycoconjugated porphyrins and chlorins in colorectal adenocarcinoma (HT29) and retinoblastoma (Y79) cell lines. , 2007, Photodiagnosis and photodynamic therapy.

[22]  M. Senge,et al.  Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer †,‡ , 2011, Photochemistry and photobiology.

[23]  P. Maillard,et al.  Glycoconjugated Porphyrins. 3. Synthesis of Flat Amphiphilic Mixed meso-(Glycosylated aryl)arylporphyrins and Mixed meso-(Glycosylated aryl)alkylporphyrins Bearing Some Mono- and Disaccharide Groups , 1995 .

[24]  H. Oppelaar,et al.  Comparison of aluminium (III) phthalocyanine tetrasulfonate‐ and meta‐tetrahydroxyphenylchlorin‐monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro , 2002, International journal of cancer.

[25]  W. Jerjes,et al.  Photodynamic therapy: The minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma , 2011, Lasers in surgery and medicine.

[26]  G. Palumbo,et al.  Enhancing Photodynamyc Therapy Efficacy by Combination Therapy: Dated, Current and Oncoming Strategies , 2011, Cancers.

[27]  S. Descroix,et al.  Enhanced detection of seven glucoconjugated and hydroxylated porphyrins and chlorins by nonaqueous capillary electrophoresis combined with stacking. , 2005, Journal of chromatography. A.

[28]  F. Guillemin,et al.  Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies. , 2008, Journal of medicinal chemistry.

[29]  P. Maillard,et al.  Vers un nouveau traitement du rétinoblastome , 2010 .

[30]  S. Songca,et al.  Solubilization of meso‐Tetraphenylporphyrin Photosensitizers by Substitution with Fluorine and with 2,3‐Dihydroxy‐1‐propyloxy Groups , 2000, The Journal of pharmacy and pharmacology.

[31]  Ravindra K. Pandey,et al.  The Role of Porphyrin Chemistry in Tumor Imaging and Photodynamic Therapy , 2011 .

[32]  H. Oppelaar,et al.  Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. , 1999, Cancer research.

[33]  F. Guillemin,et al.  Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[34]  V. Rosilio,et al.  Incorporation of glycoconjugated porphyrin derivatives into phospholipid monolayers: a screening method for the evaluation of their interaction with a cell membrane. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[35]  A. Volk,et al.  23Na MRI longitudinal follow-up of PDT in a xenograft model of human retinoblastoma. , 2009, Photodiagnosis and photodynamic therapy.

[36]  A. Fahr,et al.  Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application. , 2011, International journal of pharmaceutics.

[37]  Dewey Holten,et al.  Design, synthesis, and photophysical characterization of water-soluble chlorins. , 2008, The Journal of organic chemistry.

[38]  F. Odobel,et al.  Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin. , 2003, Bioorganic & Medicinal Chemistry Letters.

[39]  S. Thibaut,et al.  In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. , 2003, Pharmacological research.

[40]  Temocene: the porphycene analogue of temoporfin (Foscan®) , 2011 .

[41]  G. Wagnières,et al.  Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[42]  M. Senge,et al.  Lead structures for applications in photodynamic therapy. Part 1: Synthesis and variation of m-THPC (Temoporfin) related amphiphilic A2BC-type porphyrins , 2005 .

[43]  M. Senge.  Nucleophilic substitution as a tool for the synthesis of unsymmetrical porphyrins. , 2005, Accounts of chemical research.

[44]  M. Vicente,et al.  Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins. , 2008, Journal of medicinal chemistry.

[45]  V. Zorin,et al.  Fluorescence methods for detecting the kinetics of photosensitizer release from nanosized carriers , 2011 .

[46]  J. Blais,et al.  Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins. , 2005, Journal of photochemistry and photobiology. B, Biology.

[47]  Robert Pansu,et al.  Meso-tetraphenyl porphyrin derivatives: The effect of structural modifications on binding to DMPC liposomes and albumin , 2011 .

[48]  Raymond Bonnett,et al.  Chemical Aspects of Photodynamic Therapy , 2000 .

[49]  P. Hynninen,et al.  Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. , 2004, Journal of photochemistry and photobiology. B, Biology.

[50]  P. Low,et al.  Discovery and Development of Folic‐Acid‐Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases , 2008 .

[51]  P. Maillard,et al.  Simple sensitive and simultaneous high-performance liquid chromatography method of glucoconjugated and non-glucoconjugated porphyrins and chlorins using near infra-red fluorescence detection. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[52]  Á. Villanueva,et al.  Porphycenes: facts and prospects in photodynamic therapy of cancer. , 2007, Current medicinal chemistry.

[53]  P. Maillard,et al.  Speciation of New Tri- and Tetra-Glucoconjugated Tetrapyrrolic Macrocycles (Porphyrins and Chlorins): An Electronic Molecular Spectroscopy Study , 2003, Applied spectroscopy.

[54]  H. S. de Bruijn,et al.  Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window‐chamber tumor model , 2011, Lasers in surgery and medicine.

[55]  S. Ogura,et al.  Cellular uptake and photocytotoxicity of glycoconjugated chlorins in HeLa cells. , 2005, Journal of photochemistry and photobiology. B, Biology.

[56]  D. Loussouarn,et al.  Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats. , 2007, Surgical neurology.

[57]  M. Senge.  Stirring the porphyrin alphabet soup--functionalization reactions for porphyrins. , 2011, Chemical communications.

[58]  M C Berenbaum,et al.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. , 1986, British Journal of Cancer.

[59]  S. Thibaut,et al.  Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. , 2003, Journal of photochemistry and photobiology. B, Biology.

[60]  A. Bugaj.  Targeted photodynamic therapy — a promising strategy of tumor treatment , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[61]  R. Schneider,et al.  Interaction of amphiphilic chlorin-based photosensitizers with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine monolayers. , 2009, Chemistry and physics of lipids.

[62]  P. Gramatica,et al.  Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling. , 2006, Journal of medicinal chemistry.

[63]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[64]  E. Monti,et al.  Synthesis and photodynamic activity of diaryl-porphyrins characterized by the presence of nitro groups , 2006 .

[65]  I. Bronshtein,et al.  On the Correlation Between Hydrophobicity, Liposome Binding and Cellular Uptake of Porphyrin Sensitizers , 2006, Photochemistry and photobiology.

[66]  J. Lindsey.  Synthetic routes to meso-patterned porphyrins. , 2010, Accounts of chemical research.

[67]  J. Tomé,et al.  Synthesis and photophysical properties of thioglycosylated chlorins, isobacteriochlorins, and bacteriochlorins for bioimaging and diagnostics. , 2010, Bioconjugate chemistry.

[68]  S. J. Griffiths,et al.  Photodynamic therapy of ovarian tumours and normal cells using 5,10,15,20-tetra-(3-carboxymethoxyphenyl)-chlorin. , 1998, Cancer letters.

[69]  A. Fahr,et al.  Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. , 2011, International journal of pharmaceutics.

[70]  Christian Ruzié,et al.  Tailoring a bacteriochlorin building block with cationic, amphipathic, or lipophilic substituents. , 2008, The Journal of organic chemistry.

[71]  T. Knobloch,et al.  Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells , 2011, Nanotechnology.

[72]  S. Ogura,et al.  Cellular Uptake and Photocytotoxicity of Glycoconjugated Porphyrins in HeLa Cells¶ , 2004, Photochemistry and photobiology.

[73]  S. Ogura,et al.  Hydrophobicity parameters (Log P) of glycoconjugated porphyrins for photodynamic therapy evaluated by reversed phase HPLC , 2004 .

[74]  Michael R Hamblin,et al.  In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. , 2010, Journal of medicinal chemistry.

[75]  B. Sigusch,et al.  Photodynamic suppression of Enterococcus faecalis using the photosensitizer mTHPC , 2011, Lasers in surgery and medicine.

[76]  J. Blais,et al.  A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis. , 2004, Bioorganic & medicinal chemistry.

[77]  J. Strachan,et al.  Rational synthesis of meso-substituted chlorin building blocks. , 2000, The Journal of organic chemistry.

[78]  R. Farinotti,et al.  Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat. , 2006, Journal of photochemistry and photobiology. B, Biology.

[79]  B. Röder,et al.  Hydrophilicity vs hydrophobicity—varying the amphiphilic structure of porphyrins related to the photosensitizer m‐THPC , 2001 .

[80]  E. Monti,et al.  Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells. , 2004, Bioorganic & medicinal chemistry.

[81]  S. Songca.  In‐vitro activity and tissue distribution of new fluorinated meso‐tetrahydroxyphenylporphyrin photosensitizers , 2001, The Journal of pharmacy and pharmacology.

[82]  A. S. Sobolev,et al.  Targeted intracellular delivery of photosensitizers. , 2000, Progress in biophysics and molecular biology.

[83]  R. López,et al.  Quantitative structure property relationships to evaluate the photosensitizing capability in porphyrins and chlorins , 2011 .

[84]  M. Laranjo,et al.  In Vitro Photodynamic Activity of 5,15‐bis(3‐Hydroxyphenyl)porphyrin and Its Halogenated Derivatives Against Cancer Cells , 2010, Photochemistry and photobiology.

[85]  Sérgio Simões,et al.  New Halogenated Water‐Soluble Chlorin and Bacteriochlorin as Photostable PDT Sensitizers: Synthesis, Spectroscopy, Photophysics, and in vitro Photosensitizing Efficacy , 2010, ChemMedChem.

[86]  M. Senge,et al.  Efficient Synthesis of Glycoporphyrins by Microwave‐Mediated “Click” Reactions , 2010 .